Immune-related thyroid dysfunction as a positive prognostic factor for patients with lung cancer in China: a real-world retrospective study
irTD demonstrates potential as a predictive marker for long-term survival benefits in Chinese patients with lung cancer. However, our exploratory analysis indicates that this association was exclusively observed in individuals receiving immunotherapy as a second-line or subsequent treatment.
Authors
- Ruqiong Wang
- Lihua Shang (ORCID: https://orcid.org/0000-0001-6600-7959)
- Junjie Dang
- Zihan Jing
- Guiqin Wang (ORCID: https://orcid.org/0000-0002-5381-2585)
- Ge Guo (ORCID: https://orcid.org/0000-0002-7696-061X)
- Yajie Li (ORCID: https://orcid.org/0000-0002-3790-4201)
- Huan Zhang (ORCID: https://orcid.org/0000-0002-6190-296X)
- Wenbin Dou (ORCID: https://orcid.org/0000-0001-7850-9470)
- Jing Sun
Institutions
- Harbin Medical University (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
- Henan Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-12-23
- DOI
- https://doi.org/10.3389/fimmu.2024.1495460
- Citations
- 4
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.13
Funders
- Harbin Medical University